Janus Henderson Group PLC Halozyme Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 513,302 shares of HALO stock, worth $31.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

513,302

Previous 531,125 3.36%

Holding current value

$31.3 Million

Previous $21.6 Million 24.39%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $673,887 - $933,925	-17,823 Reduced 3.36%	513,302 $26.9 Million
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $3.47 Million - $4.32 Million	102,911 Added 24.03%	531,125 $21.6 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $42,449 - $53,635	1,274 Added 0.3%	428,214 $15.8 Million
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $37,590 - $45,394	-1,031 Reduced 0.24%	426,940 $16.3 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $2,816 - $3,602	-93 Reduced 0.02%	427,971 $15.4 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $7.1 Million - $12 Million	-216,078 Reduced 33.55%	428,064 $16.3 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $1.82 Million - $2.7 Million	-45,394 Reduced 6.58%	644,142 $36.7 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $57,640 - $77,462	1,496 Added 0.22%	689,536 $27.3 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $1.56 Million - $2.02 Million	-41,735 Reduced 5.72%	688,040 $30.3 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $1.86 Million - $2.39 Million	58,204 Added 8.67%	729,775 $29.1 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $419,260 - $536,922	13,176 Added 2.0%	671,571 $27 Million
Q3 2021 Nov 16, 2021	BUY	$38.47 - $46.42 $251,555 - $303,540	6,539 Added 1.0%	658,395 $26.8 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $1.22 Million - $1.61 Million	-31,313 Reduced 4.58%	651,856 $29.6 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $4.59 Million - $5.98 Million	-116,241 Reduced 14.54%	683,169 $28.5 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $2.32 Million - $3.92 Million	-89,893 Reduced 10.11%	799,410 $34.1 Million
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $22.9 Million - $26.4 Million	889,303 New	889,303 $23.4 Million

Others Institutions Holding HALO

# of Institutions

522

Shares Held

123M

Call Options Held

208K

Put Options Held

77.1K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.49B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Halozyme Therapeutics, Inc. Transaction History